Prostate cancer immunotherapy yields superior long-term survival in TRAMP mice when administered at an early stage of carcinogenesis prior to the establishment of tumor-associated immunosuppression at later stages.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples